A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

S. Salloway, R. Sperling, S. Gilman, N.C.I. Fox, K. Blennow, M. Raskind, M. Sabbagh, L.S. Honig, R. Doody, C.H. van Dyck, R. Mulnard, J. Barakos, K.M. Gregg, E. Liu, I. Lieberburg, D. Schenk, R. Black, M. Grundman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2061-2070
JournalNeurology
Volume73
Issue number24
DOIs
Publication statusPublished - 2009

Cite this

Salloway, S., Sperling, R., Gilman, S., Fox, N. C. I., Blennow, K., Raskind, M., ... Grundman, M. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73(24), 2061-2070. https://doi.org/10.1212/WNL.0b013e3181c67808